Background: After adrenalectomy, urinary fractionated metanephrine concentrations are expected to be reduced. However, there are few studies suggesting cut-offs for adrenalectomy patients. Methods: Urinary metanephrine and normetanephrine concentrations in adrenalectomy patients and two controls were compared and hormonal concentrations were evaluated via time intervals after surgery. Results: The median urinary metanephrine level after unilateral adrenalectomy was lower than that of the non-pheochromocytoma controls but comparable to healthy controls. Urinary normetanephrine concentrations did not differ between adrenalectomy patients and non-pheochromocytoma controls, although both group had levels higher than those of healthy controls. The median urinary normetanephrine level in the immediate postoperative period was higher than in the later period. Conclusions: Urinary metanephrine concentrations were lower after adrenalectomy, but urinary normetanephrine concentrations were not changed compared with the non-pheochromocytoma controls. However, urinary normetanephrine concentrations in the patient group were higher than levels in the heathy controls.
Introduction
Pheochromocytomas can be fatal due to cardiovascular deterioration. Clinical suspicion and biochemical testing are crucial for the detection of pheochromocytomas. However, studies suggesting reference intervals for adrenalectomy patients have been limited, and most institutions have used references derived from healthy subjects to assess for recurrences of pheochromocytoma.
Recently, Osinga et al 1 . suggested adjusted references in patients for pheochromocytoma based on the hypothesis that production of epinephrine will decrease after adrenalectomy; urine metanephrine (MN) was lower and urine normetanephrine (NM) was higher in adrenalectomy patients than in the healthy controls.
However, NM concentrations are affected by aging, comorbidities such as hypertension and stressful conditions. 2 As with previous literatures, we reported lower urinary NMs in healthy volunteers than in separate controls consisting of elderly hypertensive subjects. [2] [3] [4] The study from Osinga et al. 1 used healthy controls without any cardiovascular disease, and hormonal concentrations were not assessed in the immediate postoperative period when higher NM concentrations are expected. 1 Our aim was to analyse the urinary fractionated metanephrine concentrations in subjects with adrenalectomy for pheochromocytoma compared with nonpheochromocytoma controls and healthy volunteers, according to time intervals after adrenalectomy.
Methods Subjects
Subjects who underwent unilateral adrenalectomy for pheochromocytoma between 2004 and 2014 at our institution were enrolled. Patients with partial or incomplete adrenalectomy, extra-adrenal or recurrent pheochromocytoma and no postoperative biochemical tests were excluded (n ¼ 42). A total of 82 patients were eligible for this study.
Controls consisted of patients who had been confirmed as not having pheochromocytoma after adrenal surgery or had no adrenal lesion upon adrenal imaging and had been followed up more than two years or healthy normotensive individuals, as previously described. 3 
Laboratory tests
For patients, urinary fractionated metanephrine concentrations were determined at pre-and postoperative periods. For non-pheochromocytoma controls with adrenal surgery, hormone concentrations measured before adrenalectomy were used.
The 24-h urinary fractionated metanephrines were measured by an Agilent 1200 HPLC system with electrochemical detector (Agilent Technologies, Santa Clara, CA, USA) using commercially available HPLC kits (Bio-Rad Laboratories, Hercules, CA, USA). Our institution used diagnostic cut-offs of urinary metanephrines for pheochromocytomas determined in Korean non-pheochromocytoma controls. 3 
Results
Urine MN concentrations were lower in adrenalectomy patients than those in the non-pheochromocytoma controls, but were comparable with those of healthy Variables with a normal distribution, such as age and mass size, were presented as the mean AE SD, and other nonparametric variables, urine MN and urine NM were presented as median and interquartile ranges. One-way ANOVA was used for comparison of parametric variables, and the Kruskall-Wallis test was used for non-parametric variables. Adrenalectomy patients underwent unilateral adrenalectomy for pheochromocytoma and urine metanephrines were determined after adrenal surgery. Non-pheochromocytoma group consisted of patients who had been confirmed as not having pheochromocytoma after adrenal surgery or had no adrenal lesion upon adrenal imaging and had been followed up more than two years, as described in a prior study. 3 Health volunteers were healthy normotensive individuals, as described in a prior study. 3 Reference intervals of urine metanephrines were described as ranges from 2.5 to 97.5 percentiles. Adrenalectomy patients underwent unilateral adrenalectomy for pheochromocytoma and urine metanephrines were categorized by the postoperative period; <1 month, 1-12 months and >12 months. Non-pheochromocytoma group consisted of patients who had been confirmed as not having pheochromocytoma after adrenal surgery or had no adrenal lesion upon adrenal imaging and had been followed up more than two years, as described in a prior study. 3 Health volunteers were healthy normotensive individuals, as described in a prior study. 3 Proportions of women in each group by the postoperative period and in the two controls were not different. Adrenalectomy patients underwent unilateral adrenalectomy for pheochromocytoma and urine metanephrine concentrations were categorized by the postoperative period; <1 month, 1-12 months and >12 months. Non-pheochromocytoma group consisted of patients who had been confirmed as not having pheochromocytoma after adrenal surgery or had no adrenal lesion upon adrenal imaging and had been followed-up more than two years, as described in a prior study. 3 Health volunteers were healthy normotensive individuals, as described in a prior study. 3 The urine metanephrine concentrations in adrenalectomy patients did not differ in any postoperative period; these values were lower compared with the non-pheochromocytoma controls (P < 0.001), but were similar to the healthy controls.
volunteers. For urine NM concentrations, values were similar between adrenalectomy patients and the nonpheochromocytoma controls, which were both higher than those in healthy volunteers ( Table 1) . The urine MN concentrations in adrenalectomy patients did not differ in any postoperative period; these values were lower compared with the non-pheochromocytoma controls, but were similar to the healthy controls (Table 2, Figure 1 ). The urine NM concentrations of patients during each period were significantly higher than those of the healthy volunteers, although similar to those of the non-pheochromocytoma controls. The urine NM level in the immediate postoperative period (<1 month) was higher than that in the later period (>12 months) (Table 2, Figure 2 ).
Urine metanephrines in women were significantly lower for the adrenalectomy patients and two controls than those in the men, except for the urine NM concentrations in healthy volunteers (Table 3 ).
Discussion
We identified that urine MN concentrations were lower in patients who underwent unilateral adrenalectomy for pheochromocytoma as compared with non-pheochromocytoma controls, whereas urine NM concentrations were similar between these two groups. During the postoperative period, urine MN concentrations were constant in adrenalectomy patients, whereas urine NM concentrations in the early postoperative period were higher than those in later periods.
Most free MNs are derived from adrenal chromaffin cells ($90%), while NMs are mainly formed from sympathetic nerves ($75%); however, only a small fraction of them are formed via adrenal medulla. 5 Considering the compensatory production of NM from extra-adrenal sympathetic nerves, lower reference intervals of MNs are expected in adrenalectomy patients, whereas the cut-offs for NMs do not need to be modified.
Contrary to our results, a study by Osinga et al. 1 suggested higher reference values of urine NM in Figure 2 . Postoperative urine normetanephrine according to the time period. Adrenalectomy patients underwent unilateral adrenalectomy for pheochromocytoma and urine normetanephrine concentrations were categorized by the postoperative period; <1 month, 1-12 months and >12 months. Non-pheochromocytoma group consisted of patients who had been confirmed as not having pheochromocytoma after adrenal surgery or had no adrenal lesion upon adrenal imaging and had been followed-up more than two years, as described in a prior study. 3 Health volunteers were healthy normotensive individuals, as described in a prior study. 3 The urine normetanephrine concentrations of adrenalectomy patients during each period were significantly higher than those of the healthy volunteers (P < 0.001), although comparable to those of the non-pheochromocytoma controls. The urine NM level in the immediate postoperative period (<1 month) was higher than that in the later period (>12 months) (P < 0.01). adrenalectomy patients. They used 60 healthy volunteers as controls; the controls had no cardiovascular diseases, while 70% of patients had hypertension. 1 Aging and hypertension can affect urine NM concentrations; we observed a two-fold higher urine NM in non-pheochromocytoma controls than in healthy volunteers. If we used healthy volunteers as the sole control group, similar conclusions to the Osinga et al.'s might be drawn, indicating the importance of defining proper controls.
Urine NM concentrations were elevated in the early postoperative period than in the later period, which may be attributed to acute stress conditions via sympathetic nerve activation. However, urine NM concentrations were not different in patients and nonpheochromocytoma controls; thus, cut-offs for urine NM do not need to be adjusted.
Gender may affect urine metanephrines. We previously presented sex-adjusted diagnostic cut-offs of urine metanephrine concentrations, with higher cut-offs determined for men than for women, to optimize diagnostic accuracy. 3 We demonstrated hormonal trends of urine metanephrines after adrenalectomy compared with the controls, promoting the need for adjusted reference intervals. Adrenalectomy patients excreted lower concentrations of urine MN compared with the nonpheochromocytoma controls, whereas urine NM did not differ between them. However, reference ranges should be established in each laboratory, owing to different kits and assays for urine metanephrines.
